Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 | Zendy

Maria De Santis | Zendy; Joaquim Bellmunt | Zendy; Graham M. Mead | Zendy; J. Martijn Kerst | Zendy; Michael Leahy | Zendy; Pablo Maroto | Zendy; Thierry Gil | Zendy; Sandrine Marréaud | Zendy; Gedske Daugaard | Zendy; Iwona Skoneczna | Zendy; Sandra Collette | Zendy; Julie Lorent | Zendy; Ronald de Wit | Zendy; Richard Sylvester | Zendy

Open Access

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

Author(s) -

Maria De Santis,

Joaquim Bellmunt,

Graham M. Mead,

J. Martijn Kerst,

Michael Leahy,

Pablo Maroto,

Thierry Gil,

Sandrine Marréaud,

Gedske Daugaard,

Iwona Skoneczna,

Sandra Collette,

Julie Lorent,

Ronald de Wit,

Richard Sylvester

Publication year - 2011

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2011.37.3571

Subject(s) - carboplatin , medicine , gemcitabine , mucositis , chemotherapy , renal function , vinblastine , urology , cisplatin , performance status , gastroenterology , oncology , surgery

This is the first randomized phase II/III trial comparing two carboplatin-based chemotherapy regimens in patients with urothelial cancer who are ineligible ("unfit") for cisplatin chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research